Position history for WELLINGTON MANAGEMENT GROUP LLP's holdings in SYNDAX PHARMACEUTICALS INC
WELLINGTON MANAGEMENT GROUP LLP holds 123,586 shares of SNDX (SYNDAX PHARMACEUTICALS INC), worth $2.9M as of 2026-Q1. The position was increased (+246.9% shares). SNDX represents 0.0% of WELLINGTON MANAGEMENT GROUP LLP's portfolio.
Current Value
$2.9M
Current Shares
123,586
Total Value Change
-$147.8M
Total Shares Change
-7.2M
Other major holders of SNDX: BlackRock, Inc., BlackRock Finance, Inc.
Increased |
| 123,586 |
+246.9% |
| $2.9M |
| 0.0% |
| $21.40 |
42 |
| 2025-Q4 | Decreased | 35,630 | -6.8% | $748,586 | 0.0% | $20.74 | 0 |
| 2025-Q3 | Increased | 38,226 | +12.2% | $588,107 | 0.0% | $15.56 | 27 |
| 2025-Q2 | Decreased | 34,085 | -5.2% | $319,207 | 0.0% | $9.04 | 0 |
| 2025-Q1 | Decreased | 35,962 | -99.2% | $441,793 | 0.0% | $13.18 | 0 |
| 2024-Q4 | Decreased | 4.2M | -15.1% | $56M | 0.0% | $12.52 | 0 |
| 2024-Q3 | Decreased | 5M | -32.1% | $96M | 0.0% | $18.89 | 0 |
| 2024-Q2 | Decreased | 7.3M | -1.3% | $150.7M | 0.0% | $20.53 | 0 |